Podcast

Thomas Seck, MD, on Expanding Empagliflozin Use for Heart Failure

04/04/2018

Dr Thomas Seck, who is the vice president of Clinical Development and Medical Affairs at Boehringer Ingelheim Pharmaceuticals, discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.

For more information about the EMPERIAL trials, read the press release here.

For more content related to heart failure, visit HeartFailure360.

Related Content

Inflammatory Bowel Disease
Inflammatory Bowel Disease
James D. Lewis, MD, MSCE, on the Role of Diet in Crohn Disease
08/01/2019
Dr Lewis highlights the role of diet in Crohn disease, the effect of red and processed meats on risk of disease relapse, and more.
08/01/2019
Adrenal Disorders
Adrenal Disorders
Phyllis Speiser, MD, on the Endocrine Society’s Guideline for CAH Due to Steroid 21-Hydroxylase Deficiency
01/22/2020
Dr Speiser answers our questions about the Endocrine Society’s 2018 clinical practice guideline for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
01/22/2020
Rheumatology
Rheumatology
Chelsey J. Forbess Smith, MD, on Anakinra Use in Pregnancy
08/07/2018
Chelsey J. Forbess Smith, MD, from Cedars-Sinai Medical Center talks about autoimmune disease outcomes in pregnancies exposed to anakinra before, during, and after birth.
08/07/2018
Hepatology
Hepatology
Vincent Lo Re, MD, MSCE, on the Challenges of Managing Hepatitis C Virus
11/06/2010
In part 2 of this podcast series, Vincent Lo Re, MD, talks about the common pitfalls in hepatitis C virus management, as well as his best practices for reducing the risk of reinfection.
11/06/2010
Travel Medicine
Travel Medicine
Nisha Gilotra, MD, on HF Care in the COVID-19 Era
08/19/2010
She talks about how the COVID-19 pandemic has affected heart failure care at Johns Hopkins, her team's experience managing patients via telemedicine, and how she envisions restarting in-person visits.
08/19/2010